Bionano regains compliance with nasdaq minimum bid price listing requirement

San diego, aug. 21, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced that it has received a letter from the staff of the listing qualifications department of the nasdaq stock market llc (“nasdaq”) notifying the company that it has regained compliance with nasdaq's minimum bid price requirement set forth in nasdaq listing rule 5550(a)(2) for continued listing on the nasdaq capital market (the “minimum bid price requirement”). as previously announced, the company was notified by nasdaq on may 30, 2023 that it was not in compliance with the minimum bid price requirement.   the notification letter noted that for the last 10 consecutive business days, from august 7, 2023 to august 18, 2023, the closing bid price of the company's common stock has been at $1.00 per share or greater, and thus the company has regained compliance with the minimum bid price requirement and the matter is now closed.
BNGO Ratings Summary
BNGO Quant Ranking